Michael R. Liebowitz, MD
- 20Articles
- 71.9KReads
- 1996–2015Active
- 70Collaborators
- 155Citations
About
Michael R. Liebowitz, MD, has authored 20 articles between 1996 and 2015 focusing on anxiety disorders, major depressive disorder, obsessive-compulsive and related disorders, panic disorder, and anxiolytics. His publications include clinical trials and systematic reviews on treatments such as vilazodone, desvenlafaxine, venlafaxine, levetiracetam, and exposure and response prevention therapy. He has contributed to research on generalized social anxiety disorder, obsessive-compulsive disorder, and panic disorder. Frequent collaborators include Edna B. Foa, Helen Blair Simpson, and Jonathan D. Huppert.
Publications
A 12-Week Double-Blind, Placebo-Controlled, Flexible-Dose Trial of Vilazodone in Generalized Social Anxiety Disorder
November 26, 2015
Efficacy, Safety, and Tolerability of Desvenlafaxine 50 mg/d for the Treatment of Major Depressive Disorder: A Systematic Review of Clinical Trials
June 24, 2010
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.
